A resurgence in the development of oligonucleotide therapeutics has led to burgeoning pipelines across the industry. Working at the level of gene transcription and translation, these short nucleic acid drugs hold great promise for many inherited disorders and common ailments alike.
Waters LC-MS tools and techniques play a critically important role in confirming the identity and purity of these drugs, as well as quantifying their presence in biofluids.
Case Study: BioSpring Implements Waters LC-MS Workflows for Oligonucleotides to Expand Existing Portfolio